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Abstract
Background: Monthly medians of patient results are 
useful in assessment of analytical quality in medical 
 laboratories. Separate medians by gender makes it 
 possible to generate two independent estimates of con-
temporaneous errors. However, for plasma creatinine, 
reference intervals (RIs) are different by gender and also 
higher over 70 years of age.
Methods: Daily, weekly and monthly patient medians 
were calculated from the raw data of plasma creatinine 
concentrations for males between 18 and 70 years, males 
>70 years, females between 18 and 70 years and females 
>70 years.
Results: The medians of the four groups were all closely 
associated, with similar patterns. The mean of percentage 
bias from each group defined the best estimate of bias. The 
maximum half-range (%) of the bias evaluations provided 
an estimate of the uncertainty comparable to the analyti-
cal performance specifications: thus, bias estimates could 
be classified as optimum, desirable or minimum quality.
Conclusions: Medians by gender and age are useful in 
assessment of analytical stability for plasma creatinine 
concentration ranging from 60 to 90 μmol/L. The daily 
medians are valuable in rapid detection of large systematic 
errors, the weekly medians in detecting minor  systematic 
errors and monthly medians in assessment of long-term 
analytical stability.
Keywords: analytical stability; medians of plasma 
 creatinine; partitioning by gender and age; percentage 
bias; raw data for plasma creatinine.
Introduction
Plasma concentrations of creatinine are important in the 
diagnosis of kidney diseases, detection of acute kidney 
injury and monitoring of patients with renal impairment 
or failure, and it is usually requested by general practi-
tioners (GP) together with plasma electrolytes and metab-
olites as a form of case-finding or screening in patients. 
The analytical quality of plasma creatinine examinations 
is therefore critical in many clinical settings, so methods 
to assess the ongoing performance of the examinations 
are necessary.
A valid method to assess the analytical stability of 
quantitative examinations in laboratory medicine is the 
use of monthly patient medians of the results of exami-
nations on samples from patients [1]. In a previous study, 
we applied the half-range, as a percentage, of monthly 
medians from all patients as an estimate of the maximum 
bias [2]. Traditionally, the monthly medians were based 
on all patient results, but recently we have improved the 
model for serum sodium by separating the medians by 
gender [3].
For serum sodium [3] and serum albumin [4], the 
ratios between the monthly medians by gender were 
very stable in spite of considerable, but parallel, vari-
ation of the medians by separate gender due to the 
current analytical variation. Consequently, if the mean 
of the percentage deviations of the two medians from 
their targets was used as an estimate of the bias (more 
 correctly: change in bias – Δbias), then the half-range 
(%) of the ratios of medians by gender was an estimate of 
the maximum deviation of the mean of the bias from the 
accurate Δbias estimate [4].
In order to obtain objective analytical performance 
specifications (APS) for the analytical stability, we used 
the APS for bias, based on biological variation and the 
requirement to share common reference intervals (RIs), 
from Fraser et al. [5], with three levels of quality.
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For serum sodium [3] and serum albumin [4], the 
ratios of medians by gender (females/males) both 
approximate to 1.000, but this gives only assessment 
of a single concentration range. However, the measur-
and plasma creatinine has different RIs for adult males 
and females, with RIs in the Nordic countries for males: 
62.4–100.7 μmol/L, and for females: 50.5–87.5 μmol/L [6]. 
In contrast, in a later publication from Uppsala, Sweden, 
unselected 70-year-old males and females showed higher 
RIs of 59–125 μmol/L and 45–103 μmol/L, respectively [7]. 
This led to the concept of assessing the stability of plasma 
creatinine examinations by calculating the patient 
medians of separate subgroups, partitioned according to 
gender and also age.
The aim of the current investigation was therefore to 
examine the usefulness of patient medians of plasma cre-
atinine for daily, weekly and monthly assessment of ana-
lytical stability of examinations by use of raw data from 
four patient groups. The targets were previous medians for 
four groups: males 18–70 years (M 18–70), males >70 years 
(M >70), females 18–70  years (F 18–70), and females 
>70 years (F >70). Fractional bias (φbias) and percentage 
bias of the individual groups, and the four combined, were 
calculated.
Materials and methods
Analysers and results of examination of samples from 
patients
The Department of Clinical Biochemistry, Nordsjællands Hospital, 
University of Copenhagen, generated 205,573 plasma creatinine 
results for the first 6  months of 2018 from patients >18  years; 55% 
were requested by a GP. Creatinine concentrations were examined by 
use of ECREA (enzymatic) on three Siemens Dimension Vista® 1500 
instruments (Siemens Healthcare Diagnostics Inc., Newark, DE, USA) 
with calibrators and reagents from Siemens.
The study included all results from samples from male and 
female patients who were >18 years of age, with a Danish personal 
identification number, collected on working days (weekends and 
holidays were excluded to ensure a homogenous population).
From 1 April 2017, the results of the examinations were retained 
as the raw data from the analysers to allow the computations and 
calculations of medians used in the model. Sampling was changed 
from serum to lithium heparinised plasma for creatinine between 10 
and 18 September 2017.
The overall monthly (2018) analytical coefficient of variation 
(CVA) was 2.1% (n = 553, mean = 124.2 μmol/L). These data are on a 
lyophilised human serum pool (HK18) that was produced by Randox 
Laboratories Ltd (Crumlin, UK) and obtained from the Danish Insti-
tute for External Quality Assurance for Laboratories in Health Care, 
DEKS (DEKS, Rigshospitalet-Glostrup, Glostrup, Denmark).
The routine procedures for serum and plasma creatinine exam-
inations were not changed during the study nor during the subse-
quent assessment of the model.
Calculations
The calculations were performed as documented for serum sodium 
[3] and serum albumin [4]. Briefly, the raw results from the exami-
nations on samples from patients were used for calculation of daily, 
weekly and monthly medians of results for each of four groups 
according to gender and age: (M 18–70), (M >70), (F 18–70) and (F 
>70) calculated for each analyser and for the three analysers com-
bined. The medians from 1 April to 31 December 2017 for the four 
groups on all instruments were used as estimates of the stable 
medians and therefore applied as target (T) values in the calcula-
tions of bias for daily, weekly and monthly medians during the first 
6 months of 2018, (100 * {median − T}/T). The medians from 2014 to 
31 March 2017 (as integers) were also calculated in order to validate 
the previous stability. We also calculated the individual bias from 
the three instruments for the four groups and their mean bias. Dur-
ing the investigation, the instrument Vista 3 showed minor deviat-
ing results (illustrated in Figure 3B), and this is considered further 
in the Discussion.
Validation of bias based on classification of patients by 
reference intervals (RI)
We used the APS for bias from Fraser et al. [5], with the three levels of 
quality, optimum, desirable and minimum quality. We used recently 
published data on biological variation of plasma creatinine from the 
European Federation of Clinical Chemistry and Laboratory Medicine 
(EFLM) (EuBIVAS) [8]. These APS for bias are used for classification 
in the tables as the following numbers: “1”, optimum for half-range 
<1.8%, “2”, desirable for half-range <3.6%, “3”, minimum quality for 
half-range <5.4%, and “4” for larger half-ranges.
Deviations of estimated ϕbias and percentage bias
The four medians are different in concentration, but a reasonable 
assumption is that the results of the examinations are proportional 
and also that the errors are proportional with the same fractional 
bias (φbias) or in percentage: bias = 100 * (φbias − 1).
Determination of medians of creatinine and dispersions 
of distributions
The requesting of creatinine is initiated outside the laboratory 
for a variety of clinical rationale and, in consequence, the data 
on results can be considered as random. Each median of the cre-
atinine is termed and designated true plasma creatinine (TG) and 
the dispersion described by a standard error (SEG), defined by the 
selected group and the number of individuals therein. Thus, the TG 
is totally independent of the analytical performance for each group 
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under investigation, but the magnitude of the dispersion of the 
 distribution depends on SEG.
Target values
Target values are the medians calculated from the raw measurements 
of serum and plasma creatinine results in 2017 from 1 April. They are 
denoted measured targets (TM), and are specific for the local patient 
sample and the analytical performance in 2017 during the collec-
tion period and with the actual number of samples. The assumption 
is that the analytical performance and φbias are the same for the 
four groups, so TM = TG * φbias2017 where TM is defined as a target for 
 medians determined in 2018.
Raw results from the examinations on samples from 
patients
The calculated raw medians (MC) of the four groups in 2018 are 
based on two constituents: the TG (with corresponding SEG) and 
the analytical performance attained (depending on instruments, 
 calibrations, reagents and maintenance: the imprecision (ε) is 
 negligible for the medians): MC = TG * φbias2018 and the fractional 
bias of the target compared to 2017 is φbias2018/φbias2017, which 
is simply denoted “φbias” in the following since the bias of TM 
(φbias2017) is unknown.
The samples are examined randomly and are all examined 
under the same conditions (either stable or biased), and therefore, 
the calculated medians of all four groups reflect the same perfor-
mance. This means that the fractional bias is the same for all groups 
measured on the same instruments within a certain time interval, but 
distributed according to the individual SEG.
C Mbias M / T or percentage bias 100 ( bias 1)φ = = ∗ φ −
Individual estimates of bias
The percentages of bias from the individual groups are totally inde-
pendent estimates of the same bias, so the mean of these bias is 
assumed to be the best estimate of the actual bias.
Ranges of estimates
As each SEG is unknown, but important for the estimates of bias, so 
the maximum range between two or more estimates of bias from the 
different groups defines the limits for the bias, i.e. this interval is 
the largest distribution of positive and negative values of bias. The 
mean bias could be used for corrections, but the maximum range (%) 
would define the uncertainty of the correction. This range, however, 
corresponds to more than two times the performance specifications 
(positive and negative), so the maximum half-range of bias values, 
can be compared directly to the classification specifications, when 
the correction is performed.
Results
Target values
In Table 1, the target values for the medians are based on 
the raw data for creatinine medians for serum and plasma 
from the nine last months of 2017 and these are supported 
by the means of the medians from 2014 to March 2017.
There was no detectable difference between 
the  results from serum and plasma samples. By 
 changing from serum to plasma creatinine, there was 
no  systematic change and the Deming regression line 
was plasma = 0.9916  serum + 1.0193  within the range 
25–1000 μmol/L.
Medians
The dispersion of monthly median concentrations is 
 illustrated in Figure 1A and the closeness among the 
gender medians over time are illustrated in Figure 1B for 
the genders between 18 and 70 years and for the genders 
>70 years in Figure 1C. In both Figure 1B and C, the data are 
adapted to their target values, and the three levels of exam-
ination bias from the targets are illustrated with the hori-
zontal lines. Likewise, the weekly medians are shown in 
Supplementary Figure 1A and B, and daily medians in Sup-
plementary Figure 2A and B for the genders between 18 and 
70 years and for the genders >70 years in A and B, respec-
tively, and all adjusted to their target values. The calculated 
characteristics for daily, weekly and monthly medians of 
plasma creatinine from the four groups  (combined from the 
three instruments) are presented in Supplementary Table 1.
Bias
The estimated daily, weekly and monthly bias for the four 
groups and their means are shown in Tables 2–4 with 
Table 1: Target values based on serum and plasma creatinine 
medians in 2017 (from April).
Gender Males Females
Age, years 18–70 >70 18–70 >70
Target median, μmol/La 79.0 88.5 62.6 69.1
Mean of medians, μmol/L
2014–March 2017b
79 89 63 69
aMedians calculated after April 2017 are with one significant figure 
after the decimal point on plasma and serum samples. bMedians 
calculated before April 2017 are integers.
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maximum half-range and classifications of quality for 
each according to the APS described. The four groups of 
monthly bias are illustrated together with the mean bias 
in Figure 2. The corresponding weekly medians with bias 
are shown in Figure 3A, whereas the weekly results for the 
instrument Vista 3 are illustrated in Figure 3B. The three 
levels of examination bias from the targets are illustrated 
by the horizontal lines.
Discussion
Target values and analytical stability
Traceability of measurands is central in laboratory med-
icine, but may be costly to attain and may need consid-
erable resources every time new calibration or reagents 
are introduced if traceability is to be maintained. If this 
process could be restricted to be performed, e.g. once 
every year or second year, it would save financial and 
other resources. However, the assessment of analytical 
stability in the time between the traceability processes, 
through use of frozen sera in daily internal control strat-
egies, is also costly, and the materials used may not be 
 sufficiently commutable. Samples from patients, however, 
are commutable, by definition, and are available and cost-
less if adopted for quality management: thus, by use of 
calculated patient medians, the examination stability 
can be assessed [1, 2] for most measurands in laboratory 
medicine without biological rhythms. This method has 
been improved for serum sodium [3] by separating the 
medians by gender, in order to get two independent esti-
mates of bias, which can confirm (or refute) each other. A 
similar approach was used for serum albumin, where the 
medians by gender were restricted to results requested by 
GP, which solved the problem of albumin dependence on 
posture, since all these patients underwent phlebotomy 
in a sitting position [4]. For the use of medians in valida-
tion of analytical stability, it is vital to calculate the meas-
urand concentrations directly from the raw data in order 
to obtain the needed accuracy to estimate the analytical 
bias, e.g. creatinine mean of the monthly bias for females 
(18–70  years) is +0.11% (Table 4); without the needed 
 decimals, the  estimate would have been 0%, and the 
target and bias concentrations would both be 63 μmol/L.
For plasma creatinine, higher concentrations are 
found at the age of 70 years [7], and recently a publica-
tion (in Swedish) of even higher RIs for males (63–158 
μmol/L) and females (51–136 μmol/L) of 80 years has been 
published [9], which confirms our further partitioning 
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Figure 1: Monthly median creatinine plasma concentrations for  
the six first months of 2018.
(A) The four groups: males (M): (M 18–70) (solid light blue), (M >70) 
(solid dark blue), females (F): (F 18–70) (dotted light red) and (F >70) 
(dotted dark red). (B) The medians by gender in 18–70 years, where 
the ordinates are adjusted to the target values (M 18–70): 79.0 μmol/L 
and (F 18–70): 62.6 μmol/L (same colours as in Figure 1A). (C) The 
medians by gender >70 years, where the ordinates are adjusted to 
the target values (M >70): 88.5 μmol/L and (F >70): 69.1 μmol/L (same 
colours as in Figure 1A). The horizontal lines in the figures (B and C) 
are the targets (dark yellow), optimum for φbias, ±1.8% (green dotted), 
desirable, ±3.6% (red) and minimum quality, ±5.4% (red dotted).
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of the medians by gender into groups below and above 
70  years. This provides four medians in the concentra-
tion interval 62–88 μmol/L, as shown in Table  1 and 
Figure 1A.
Variations in estimates of examination 
stability
All patient results are influenced by the same examination 
performance and, when this is proportional, all results 
from patient are affected by the same fractional error or 
percentage error. The assumed proportionality is con-
firmed by the maximum half-range results for bias which, 
for monthly results, reduces to 0.32% for the two groups 
(males and females 18–70 years), but to 0.93% for all four 
groups, as shown in Table 4, due to the less stable TG for 
males >70 years.
Long-term stability and minor errors in the 
instrument Vista 3
The means of monthly medians for all four groups are 
within 0.5% of their targets, which indicates considerable 
Table 2: Performance bias for plasma creatinine (January–June 2018). Daily bias for plasma creatinine concentration medians by genders 
and age for all analysers.
Gender Males Males Females Females All four groups Two groups
Day/age, years 18–70 >70 18–70 >70 >18 18–70
Target, μmol/L 79.0 88.5 62.6 69.1
Median, μmol/L 79.1 88.8 62.5 68.8
Mean bias, % 0.21 0.41 −0.04 −0.32 0.07 0.09
Maximum half-range, % 5.18 1.89
Classificationa 3 2
aClassification: “1” for half-range <1.8%, “2” for half-range <3.6%, “3” for half-range <5.4%, and “4” for larger half-ranges according to 
Fraser et al. [5].
Table 3: Performance bias for plasma creatinine (January–June 2018). Weekly bias for plasma creatinine concentration medians by  
gender and age for all analysers.
Gender Males Males Females Females All four groups Two groups
Week/age, years 18–70 >70 18–70 >70 >18 18–70
Target, μmol/L 79.0 88.5 62.6 69.1
Median, μmol/L 79.1 88.8 62.6 68.9
Mean bias, % 0.13 0.31 −0.09 −0.42 −0.02 0.02
Maximum half-range, % 2.44 0.91
Classificationa 2 1
aClassification: “1” for half-range <1.8%, “2” for half-range <3.6%, “3” for half-range <5.4%, and “4” for larger half-ranges according to 
Fraser et al. [5].
Table 4: Performance bias for plasma creatinine (January–June 2018). Monthly bias for plasma creatinine concentration medians by gender 
and age for all analysers.
Gender Males Males Females Females All four groups Two groups
Month/age, years 18–70 >70 18–70 >70 >18 18–70
Target, μmol/L 79.0 88.5 62.6 69.1
Median, μmol/L 79.4 88.8 62.7 69.1
Mean bias, % 0.18 0.26 −0.11 −0.34 0.00 0.04
Maximum half-range, % 0.93 0.32
Classificationa 1 1
aClassification: “1” for half-range <1.8%, “2” for half-range <3.6%, “3” for half-range <5.4%, and “4” for larger half-ranges according to 
Fraser et al. [5].
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long-term stability within the optimum APS during this 
study (Table 4), but the daily, weekly and monthly medians 
for individual instruments might disclose general or local 
errors in the three instruments. Thus, the Vista 3 showed 
a bias of approximately −4% after new calibration at week 
9, and a new bias of approximately +2% at a renewed cali-
bration in week 15 as described in Figure 3B. This minor 
deviation introduced in week 9 is also reflected in the com-
bined weekly bias plot (Figure 3A), but only to the level of 
approximately −1.5% and not much in evidence from week 
15. This situation can be compared to our results for serum 
albumin, where a comparable bias was found for all three 
instruments and could be assigned to the common calibra-
tor and reagents [4]. The effect is also seen in the monthly 
bias plot (Figure 2). The bias was not disclosed by the 
routine procedure since this was within the acceptance 
limits (±4.4 μmol/L) laid down for accreditation in Hillerød.
Relationship between the bias the maximum 
half-range and analytical performance 
specifications
The use of bias is likely to be easy to understand, but the 
half-range and the relation between the maximum half-
range and APS are more complicated.
In Figure 3A, the four estimates of bias at week 9 are 
(M 18–70): −0.63%, (M >70): −0.68%, (F 18–70): −0.64% 
and (F >70): −1.45%, and the mean bias is −0.85%. The 
 correction of bias is then −0.85%. But the range of all 
four estimates is 0.81% (from −0.64% to −1.45%). After 
 correction using −0.85%, the individual bias values 
change to +0.22%, +0.17%, +0.21% and −0.60%. Thus, 
the corrected result is an unbiased value with the four 
estimates scattered around zero defining the range of 
individual estimates of bias. This scatter is only of a small 
range (for week 9), but varies for the different weeks and 
the maximum half-range defines the largest deviation 
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Figure 2: Monthly bias estimated from deviations of medians from 
their targets.
Bias for the four groups and for the mean of all four. (M 18–70) 
(solid light blue), (M >70) (solid dark blue), (F 18–70) (dotted light 
red), (F >70) (dotted dark red) and mean bias (thick black line). The 
horizontal lines are the targets (dark yellow), optimum for φbias, 
±1.8% (green dotted), desirable, ±3.6% (red) and minimum quality, 
±5.4% (red dotted).
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Figure 3: Weekly bias estimated from deviations of medians from 
their targets.
(A) Bias for the four groups and for the mean of all four.  
(M 18–70) (solid light blue), (M >70) (solid dark blue), (F 18–70) 
(dotted light red), (F >70) (dotted dark red) and mean bias (thick 
black line). (B) Weekly bias for the single instrument Vista3. 
The curves are (M 18–70): (solid green), (F 18–70): (dotted green) 
together with the frozen serum control (solid black). The horizontal 
lines are the zero bias (dark yellow), optimum for φbias, ±1.8% 
(green dotted), desirable, ±3.6% (red) and minimum quality, ±5.4% 
(red dotted).
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from the mean correction. This deviation from the mean 
of the individual estimates is larger than the uncertainty 
of the mean estimate and defines a maximum error of 
the correction, and it is therefore comparable to the APS, 
which define the maximum allowable bias for use of 
common RIs [5].
The maximum weekly half-range for bias of the four 
groups is 2.44% (Table 3) which is comparable with the 
desirable APS for bias (3.6% [5]) and thus describe the 
weekly performance as clearly sufficient within the con-
centration range of 60–90 μmol/L.
Furthermore, corrections with the calculated monthly 
bias will maintain the corrected monthly bias within 
0.93%, which is about half of the desirable APS of 1.8%.
Had we used only the two estimates of bias from males 
and females from 18 to 70 years in the correction, where 
the weekly maximum half-range is 0.91% and the monthly 
is 0.32% (Tables 3 and 4), the performance quality could 
be further improved. This demonstrates a considerably 
possibility for obtaining even higher accuracy if needed, 
but it might result in frequent corrections. Thus, we 
suggest that the user of this approach objectively selects 
the number of medians to apply in the relevant strategy.
Use of daily, weekly and monthly bias in 
routine practice
The monthly bias provide documentation of the examina-
tion stability (Figure 2) whereas the weekly bias are more 
operational in the process of revealing minor systematic 
errors in single instruments, as described for the Vista 3 
above, while the results for the individual instruments can 
be useful in trouble-shooting, to validate the instrument 
calibration and separate instrument changes, in contrast 
to the common reagents and calibrator numbers used in 
all instruments.
If the daily bias estimate is outside the minimum 
APS, the deviation is considerable. If beyond desirable 
APS, it should be regarded as a warning, and the result 
should be compared to the previous bias results, to see 
if there is a trend, which is confirmed or refuted by the 
weekly bias. The sharpest bias is the combination of both 
genders 18–70 years, so they should be the first to detect 
systematic errors from the bias; but the other medians can 
confirm or refute the result and be used in the final deci-
sion the next day. Consequently, the daily medians can be 
used in the daily trouble-shooting for major problems, the 
weekly medians to disclose minor errors and the monthly 
medians to assess the long-term stability.
Plasma creatinine concentration and 
estimated glomerular filtration rate (eGFR)
Plasma creatinine concentration is the base in the calcula-
tion of eGFR, through use of a complicated formula, which 
is normalised to a standard body surface area of 1.73 m2 
(mL min−1 [1.73 m2]−1), but also related to age and gender, 
and sometimes race [10]. eGFR is of vital importance for 
the correct classification of chronic kidney disease, so the 
consequence of a biased plasma creatinine result may be 
erroneous diagnosis. A recent publication indicates that 
an analytical error to eGFR is acceptable if it does not 
exceed 10% [11], and thus recommend that the limit for 
analytical bias is 5% for plasma creatinine concentrations 
above 100 μmol/L. This recommended limit for bias is 
practically the same as the daily maximum half-range (%) 
for the four groups (Table 2), so our separation of medians 
by gender and age is also clinical useful, and will be valu-
able for most large clinical laboratories, using enzymatic 
methods to plasma creatinine measurements. The other 
creatinine methods based on Jaffè-endpoint, Jaffè-kinetic 
and Jaffè-compensated are non-specific, and cannot be 
compensated by intensive standardisation [11].
Ratios between patient medians partitioned 
by gender
For assessment of serum sodium [3] and serum albumin [4] 
using patient medians, we calculated ratios between the 
genders to validate the examination quality in relation to 
the APS. In the present study, we have used target values 
for plasma creatinine, which allows calculation of bias. The 
assessment of bias values is much easier to understand and 
apply, and we advocate use of these instead of ratios.
Conclusions
 – Raw data from the analytical system are necessary 
to guarantee the number of significant figures in 
plasma creatinine results in order to generate patient 
medians with the needed accuracy.
 – The daily medians are useful in the daily trouble-
shooting of large systematic problems, the weekly 
medians in detecting minor biases and monthly medi-
ans in assessment of long-term analytical stability.
 – Patient medians partitioned by gender and age 
are useful in assessment of examination stability 
within the plasma creatinine concentrations from 
60 to 90 μmol/L.
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 – The mean of bias from medians by gender of patients 
18–70 years of age are the most accurate for estima-
tion of bias.
 – The half-range of individual bias estimates are compa-
rable to the APS and can classify the examination qual-
ity obtained as optimal, desirable or minimum quality.
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